Literature DB >> 9329787

Partial characterization of insulin resistance in adipose tissue of monosodium glutamate-induced obese rats.

S Zórad1, L Macho, D Jezová, M Ficková.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9329787     DOI： 10.1111/j.1749-6632.1997.tb51867.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.

Authors:  Stefan Zorad; Jing-tao Dou; Julius Benicky; Daniel Hutanu; Katarina Tybitanclova; Jin Zhou; Juan M Saavedra
Journal:  Eur J Pharmacol       Date:  2006-09-09       Impact factor: 4.432

2.  Monosodium glutamate (MSG) intake is associated with the prevalence of metabolic syndrome in a rural Thai population.

Authors:  Tonkla Insawang; Carlo Selmi; Ubon Cha'on; Supattra Pethlert; Puangrat Yongvanit; Premjai Areejitranusorn; Patcharee Boonsiri; Tueanjit Khampitak; Roongpet Tangrassameeprasert; Chadamas Pinitsoontorn; Vitoon Prasongwattana; M Eric Gershwin; Bruce D Hammock
Journal:  Nutr Metab (Lond)       Date:  2012-06-08       Impact factor: 4.169

3.  Response to Dr. Roger's letter: further studies are necessary in order to conclude a causal association between the consumption of monosodium L-glutamate (MSG) and the prevalence of metabolic syndrome in the rural Thai population.

Authors:  Tonkla Insawang; Carlo Selmi; Ubon Cha'on; M Eric Gershwin; Puangrat Yongvanit; Vitoon Prasongwattana
Journal:  Nutr Metab (Lond)       Date:  2013-01-15       Impact factor: 4.169

4.  Inflammation and hypertension: are there regional differences?

Authors:  Patricio López-Jaramillo; Carlos Velandia-Carrillo; Julie Alvarez-Camacho; Daniel Dylan Cohen; Tatiana Sánchez-Solano; Gabriela Castillo-López
Journal:  Int J Hypertens       Date:  2013-03-21       Impact factor: 2.420
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.